drugset / Trial / NCT03657407

B&O for TLH Post-operative Pain and Nausea

NCT03657407

Phase 4 Completed 56 enrolled Anna Reinert University of Maryland · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A prospective, single-center, double-blind, randomized, placebo-controlled trial to assess the impact of immediate post-operative placement of a Belladonna and Opium (B\&O) rectal suppository on postoperative pain and nausea following laparoscopic and robot-assisted hysterectomy.

Timeline

Start
2016-06-01
Primary completion
2017-05-31
Completion
2017-05-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Belladonna Unknown 16.2 mg Rectal
Comparator opium Traditional medicine (herbal / TCM) 60 mg Rectal

Indications

No indication recorded.